Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Frech

Showing results (61-70 of 164) with videos related to

Pageof 17
Sort By:
Rheumatic Diseases Clinics of North America|April 7, 2023
Expanding the Treatment Team: What Is the Role for Occupational Therapy, Physical Therapy, Wound Care, and Nutritional Support in Systemic Sclerosis?Tracy M Frech, Janet L Poole, Maureen Murtaugh, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 13, 2009
Highly selective dehydrogenative silylation of alkenes catalyzed by rhenium complexesYanfeng Jiang, Olivier Blacque, Thomas Fox, et al.
The Lancet. Rheumatology|January 24, 2024
Treatment efficacy in secondary Raynaud's phenomenonJohn D Pauling, Theresa Smith, Robyn T Domsic, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Patient participation in patient-reported outcome instrument development in systemic sclerosisJohn D Pauling, Tracy M Frech, Robyn T Domsic, et al.
The Journal of Biological Chemistry|September 15, 1991
p21 with a phenylalanine 28----leucine mutation reacts normally with the GTPase activating protein GAP but nevertheless has transforming propertiesJ Reinstein, I Schlichting, M Frech, et al.
British Dental Journal|September 24, 2016
Orofacial manifestations of systemic sclerosisB J Veale, R Y Jablonski, T M Frech, et al.
Leukemia|November 23, 2011
Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter bindingA Seshire, T Rößiger, M Frech, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
A normal diffusing capacity of the lungs for carbon monoxide is rare in incidental pulmonary arterial hypertension in systemic sclerosis: Data from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma cohortRebecca S Overbury, Maureen A Murtaugh, Tracy M Frech, et al.
Arthritis Care & Research|September 26, 2025
Rethinking Strategies for a Pharmaceutical Approach to Pain Related to Connective Tissue-Related Raynaud Phenomenon in the United StatesTracy M Frech, Charles G Frech, W David Merryman, et al.
Arthritis Care & Research|April 24, 2014
Parental influence on systemic sclerosisTracy M Frech, Richard Pimentel, Geraldine Mineau, et al.
Pageof 17

Showing results (61-70 of 164) with videos related to

Sort By:
Pageof 17
Rheumatic Diseases Clinics of North America|April 7, 2023
Expanding the Treatment Team: What Is the Role for Occupational Therapy, Physical Therapy, Wound Care, and Nutritional Support in Systemic Sclerosis?Tracy M Frech, Janet L Poole, Maureen Murtaugh, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 13, 2009
Highly selective dehydrogenative silylation of alkenes catalyzed by rhenium complexesYanfeng Jiang, Olivier Blacque, Thomas Fox, et al.
The Lancet. Rheumatology|January 24, 2024
Treatment efficacy in secondary Raynaud's phenomenonJohn D Pauling, Theresa Smith, Robyn T Domsic, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Patient participation in patient-reported outcome instrument development in systemic sclerosisJohn D Pauling, Tracy M Frech, Robyn T Domsic, et al.
The Journal of Biological Chemistry|September 15, 1991
p21 with a phenylalanine 28----leucine mutation reacts normally with the GTPase activating protein GAP but nevertheless has transforming propertiesJ Reinstein, I Schlichting, M Frech, et al.
British Dental Journal|September 24, 2016
Orofacial manifestations of systemic sclerosisB J Veale, R Y Jablonski, T M Frech, et al.
Leukemia|November 23, 2011
Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter bindingA Seshire, T Rößiger, M Frech, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
A normal diffusing capacity of the lungs for carbon monoxide is rare in incidental pulmonary arterial hypertension in systemic sclerosis: Data from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma cohortRebecca S Overbury, Maureen A Murtaugh, Tracy M Frech, et al.
Arthritis Care & Research|September 26, 2025
Rethinking Strategies for a Pharmaceutical Approach to Pain Related to Connective Tissue-Related Raynaud Phenomenon in the United StatesTracy M Frech, Charles G Frech, W David Merryman, et al.
Arthritis Care & Research|April 24, 2014
Parental influence on systemic sclerosisTracy M Frech, Richard Pimentel, Geraldine Mineau, et al.
Pageof 17